[Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes].
We report on the therapeutic effect of a combination of piracetam and dihydroergocristine in 55 vertiginous patients, of both sexes, between 20 and 67 years of age, from different causes (not scheduled for surgery). The trial lasted 3 months, and the drugs were taken twice daily. Aside from one case who stopped the drug therapy because of intolerance, the conclusions drawn by the AA. are seemingly good, both subjectively and objectively (audiometric and electronystagmographic tracings).
Ordosgoitia
H
H
Castro
C
C
Carbayeda
M
M
Labella
T
T
D000328:Adult; D000368:Aged; D004088:Dihydroergotoxine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010889:Piracetam / Q000008:administration & dosage / Q000627:therapeutic use*; D011760:Pyrrolidinones / Q000627:therapeutic use*; D014717:Vertigo / Q000188:drug therapy* / Q000209:etiology
D011760:Pyrrolidinones; D004088:Dihydroergotoxine; D010889:Piracetam
Ensayo clínico sobre la aplicación de la asociación piracetam y dihidroergocristina en cuadros vertiginosos de diferente etiología.